512
Participants
Start Date
October 31, 2002
Study Completion Date
November 30, 2006
dalteparin
The St. George Hospital, Kogarah
Sir Charles Gairdner Hospital, Nedlands
Royal Perth Hospital, Perth
Ospedali Riuniti di Bergamo, Bergamo
Henry Ford Hospital, Detroit
Kellogg Cancer Center - Evanston Northwestern Healthcare, Evanston
Huntsman Cancer Institute, Salt Lake City
Cross Cancer Institute, Edmonton
CancerCare Manitoba, Winnipeg
Nova Scotia Cancer Centre, Halifax
The Ottawa Hospital Regional Cancer Centre, Ottawa
Toronto-Sunnybrook Regional Cancer Centre, Toronto
Princess Margaret Hospital, Toronto
Università di Perugia, Perugia
Collaborators (1)
Pfizer
INDUSTRY
Ontario Clinical Oncology Group (OCOG)
OTHER